Annual Gross Profit
$56.35 M
-$14.07 M-19.97%
31 December 2023
Summary:
Nektar Therapeutics annual gross profit is currently $56.35 million, with the most recent change of -$14.07 million (-19.97%) on 31 December 2023. During the last 3 years, it has fallen by -$77.08 million (-57.77%). NKTR annual gross profit is now -95.18% below its all-time high of $1.17 billion, reached on 31 December 2018.NKTR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$19.69 M
+$5.94 M+43.20%
30 September 2024
Summary:
Nektar Therapeutics quarterly gross profit is currently $19.69 million, with the most recent change of +$5.94 million (+43.20%) on 30 September 2024. Over the past year, it has increased by +$7.98 million (+68.10%). NKTR quarterly gross profit is now -98.18% below its all-time high of $1.08 billion, reached on 30 June 2018.NKTR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$63.15 M
+$7.98 M+14.46%
30 September 2024
Summary:
Nektar Therapeutics TTM gross profit is currently $63.15 million, with the most recent change of +$7.98 million (+14.46%) on 30 September 2024. Over the past year, it has increased by +$7.60 million (+13.69%). NKTR TTM gross profit is now -95.31% below its all-time high of $1.35 billion, reached on 30 June 2018.NKTR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.0% | +68.1% | +13.7% |
| 3 y3 years | -57.8% | +0.4% | -18.3% |
| 5 y5 years | -95.2% | -18.9% | -35.4% |
NKTR Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -57.8% | at low | at high | +68.1% | -19.7% | +15.0% |
| 5 y | 5 years | -95.2% | at low | -57.9% | +68.1% | -55.6% | +15.0% |
| alltime | all time | -95.2% | +2461.6% | -98.2% | +2912.7% | -95.3% | +3608.1% |
Nektar Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.69 M(+43.2%) | $63.15 M(+14.5%) |
| June 2024 | - | $13.75 M(+4.9%) | $55.17 M(+0.4%) |
| Mar 2024 | - | $13.11 M(-21.1%) | $54.92 M(-2.5%) |
| Dec 2023 | $56.35 M(-20.0%) | $16.60 M(+41.7%) | $56.35 M(+1.5%) |
| Sept 2023 | - | $11.71 M(-13.3%) | $55.54 M(-11.1%) |
| June 2023 | - | $13.51 M(-7.1%) | $62.48 M(-4.5%) |
| Mar 2023 | - | $14.53 M(-8.0%) | $65.45 M(-7.1%) |
| Dec 2022 | $70.42 M(-8.6%) | $15.79 M(-15.3%) | $70.42 M(-4.2%) |
| Sept 2022 | - | $18.65 M(+13.3%) | $73.48 M(-1.3%) |
| June 2022 | - | $16.47 M(-15.6%) | $74.43 M(-5.3%) |
| Mar 2022 | - | $19.51 M(+3.5%) | $78.63 M(+2.1%) |
| Dec 2021 | $77.01 M(-42.3%) | $18.85 M(-3.9%) | $77.01 M(-0.4%) |
| Sept 2021 | - | $19.61 M(-5.1%) | $77.30 M(-5.9%) |
| June 2021 | - | $20.66 M(+15.5%) | $82.16 M(-21.4%) |
| Mar 2021 | - | $17.89 M(-6.5%) | $104.57 M(-21.6%) |
| Dec 2020 | $133.44 M(+43.1%) | $19.14 M(-21.8%) | $133.44 M(-6.1%) |
| Sept 2020 | - | $24.46 M(-43.2%) | $142.17 M(+0.1%) |
| June 2020 | - | $43.07 M(-7.9%) | $142.00 M(+21.1%) |
| Mar 2020 | - | $46.76 M(+67.8%) | $117.22 M(+25.7%) |
| Dec 2019 | $93.24 M(-92.0%) | $27.87 M(+14.7%) | $93.24 M(-4.6%) |
| Sept 2019 | - | $24.29 M(+32.8%) | $97.73 M(+1.4%) |
| June 2019 | - | $18.30 M(-19.7%) | $96.42 M(-91.7%) |
| Mar 2019 | - | $22.78 M(-29.6%) | $1.16 B(-0.7%) |
| Dec 2018 | $1.17 B(+321.7%) | $32.37 M(+40.8%) | $1.17 B(-4.4%) |
| Sept 2018 | - | $22.98 M(-97.9%) | $1.22 B(-9.2%) |
| June 2018 | - | $1.08 B(+3349.6%) | $1.35 B(+364.4%) |
| Mar 2018 | - | $31.37 M(-63.4%) | $289.94 M(+4.6%) |
| Dec 2017 | $277.16 M(+105.0%) | $85.71 M(-41.8%) | $277.16 M(+24.7%) |
| Sept 2017 | - | $147.25 M(+475.2%) | $222.30 M(+113.0%) |
| June 2017 | - | $25.60 M(+37.7%) | $104.35 M(+0.5%) |
| Mar 2017 | - | $18.60 M(-39.7%) | $103.81 M(-23.2%) |
| Dec 2016 | $135.22 M(-31.2%) | $30.85 M(+5.3%) | $135.22 M(-0.1%) |
| Sept 2016 | - | $29.30 M(+16.9%) | $135.38 M(-15.0%) |
| June 2016 | - | $25.06 M(-49.9%) | $159.27 M(+8.8%) |
| Mar 2016 | - | $50.01 M(+61.3%) | $146.34 M(-25.6%) |
| Dec 2015 | $196.68 M(+14.2%) | $31.01 M(-41.7%) | $196.68 M(+9.9%) |
| Sept 2015 | - | $53.19 M(+338.6%) | $178.93 M(-28.3%) |
| June 2015 | - | $12.13 M(-87.9%) | $249.39 M(-4.3%) |
| Mar 2015 | - | $100.36 M(+657.2%) | $260.67 M(+51.4%) |
| Dec 2014 | $172.17 M(+55.9%) | $13.25 M(-89.3%) | $172.17 M(-4.9%) |
| Sept 2014 | - | $123.65 M(+428.3%) | $181.11 M(+71.7%) |
| June 2014 | - | $23.41 M(+97.3%) | $105.49 M(-4.9%) |
| Mar 2014 | - | $11.86 M(-46.5%) | $110.93 M(+0.5%) |
| Dec 2013 | $110.41 M(+117.5%) | $22.19 M(-53.8%) | $110.41 M(+8.2%) |
| Sept 2013 | - | $48.03 M(+66.5%) | $102.08 M(+56.5%) |
| June 2013 | - | $28.85 M(+154.4%) | $65.23 M(+23.4%) |
| Mar 2013 | - | $11.34 M(-18.1%) | $52.86 M(+4.1%) |
| Dec 2012 | $50.76 M | $13.86 M(+23.9%) | $50.76 M(+7.5%) |
| Sept 2012 | - | $11.18 M(-32.1%) | $47.24 M(-18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $16.48 M(+78.3%) | $58.09 M(+14.4%) |
| Mar 2012 | - | $9.24 M(-10.5%) | $50.80 M(+2.4%) |
| Dec 2011 | $49.59 M(-62.8%) | $10.33 M(-53.1%) | $49.59 M(-33.3%) |
| Sept 2011 | - | $22.03 M(+139.7%) | $74.33 M(-11.5%) |
| June 2011 | - | $9.19 M(+14.4%) | $83.98 M(-25.3%) |
| Mar 2011 | - | $8.04 M(-77.1%) | $112.47 M(-15.7%) |
| Dec 2010 | $133.37 M(+225.4%) | $35.08 M(+10.7%) | $133.37 M(+3.8%) |
| Sept 2010 | - | $31.68 M(-15.9%) | $128.50 M(+27.3%) |
| June 2010 | - | $37.67 M(+30.2%) | $100.90 M(+53.3%) |
| Mar 2010 | - | $28.94 M(-4.2%) | $65.84 M(+60.6%) |
| Dec 2009 | $40.98 M(-25.7%) | $30.20 M(+638.6%) | $40.98 M(+41.6%) |
| Sept 2009 | - | $4.09 M(+56.7%) | $28.94 M(-29.3%) |
| June 2009 | - | $2.61 M(-36.1%) | $40.94 M(-21.0%) |
| Mar 2009 | - | $4.08 M(-77.5%) | $51.80 M(-6.1%) |
| Dec 2008 | $55.15 M(-56.1%) | $18.16 M(+12.8%) | $55.15 M(-29.9%) |
| Sept 2008 | - | $16.09 M(+19.5%) | $78.72 M(-14.0%) |
| June 2008 | - | $13.47 M(+81.3%) | $91.49 M(-12.4%) |
| Mar 2008 | - | $7.43 M(-82.2%) | $104.45 M(-16.8%) |
| Dec 2007 | $125.51 M(+26.0%) | $41.73 M(+44.6%) | $125.51 M(+11.5%) |
| Sept 2007 | - | $28.86 M(+9.2%) | $112.55 M(+1.3%) |
| June 2007 | - | $26.43 M(-7.3%) | $111.14 M(+2.8%) |
| Mar 2007 | - | $28.49 M(-0.9%) | $108.16 M(+8.6%) |
| Dec 2006 | $99.63 M(-2.8%) | $28.76 M(+4.8%) | $99.63 M(-5.0%) |
| Sept 2006 | - | $27.45 M(+17.1%) | $104.87 M(+0.3%) |
| June 2006 | - | $23.45 M(+17.5%) | $104.57 M(+3.0%) |
| Mar 2006 | - | $19.96 M(-41.3%) | $101.57 M(-1.0%) |
| Dec 2005 | $102.55 M(+8.6%) | $34.00 M(+25.2%) | $102.55 M(+9.3%) |
| Sept 2005 | - | $27.15 M(+32.8%) | $93.86 M(+3.4%) |
| June 2005 | - | $20.45 M(-2.4%) | $90.78 M(-1.5%) |
| Mar 2005 | - | $20.95 M(-17.3%) | $92.12 M(-2.5%) |
| Dec 2004 | $94.47 M(+3.2%) | $25.31 M(+5.2%) | $94.47 M(+2.7%) |
| Sept 2004 | - | $24.07 M(+10.4%) | $91.97 M(+0.3%) |
| June 2004 | - | $21.79 M(-6.4%) | $91.72 M(-2.4%) |
| Mar 2004 | - | $23.30 M(+2.1%) | $93.97 M(+2.6%) |
| Dec 2003 | $91.58 M(+4.3%) | $22.82 M(-4.2%) | $91.58 M(+1.9%) |
| Sept 2003 | - | $23.82 M(-0.9%) | $89.88 M(+2.9%) |
| June 2003 | - | $24.04 M(+15.0%) | $87.34 M(+4.1%) |
| Mar 2003 | - | $20.91 M(-1.0%) | $83.88 M(-4.5%) |
| Dec 2002 | $87.83 M(+19.8%) | $21.11 M(-0.8%) | $87.83 M(-1.0%) |
| Sept 2002 | - | $21.28 M(+3.4%) | $88.69 M(+1.0%) |
| June 2002 | - | $20.58 M(-17.2%) | $87.84 M(+30.6%) |
| Mar 2002 | - | $24.86 M(+13.1%) | $67.26 M(+58.6%) |
| Dec 2001 | $73.30 M(+804.9%) | $21.98 M(+7.6%) | $42.40 M(+107.6%) |
| Sept 2001 | - | $20.43 M(+398.2%) | $20.43 M(+788.1%) |
| Dec 1996 | $8.10 M(+80.0%) | - | - |
| Dec 1995 | $4.50 M(+104.5%) | - | - |
| Dec 1994 | $2.20 M | $4.10 M(-920.0%) | $2.30 M(-227.8%) |
| Sept 1994 | - | -$500.00 K(-28.6%) | -$1.80 M(+38.5%) |
| June 1994 | - | -$700.00 K(+16.7%) | -$1.30 M(+116.7%) |
| Mar 1994 | - | -$600.00 K | -$600.00 K |
FAQ
- What is Nektar Therapeutics annual gross profit?
- What is the all time high annual gross profit for Nektar Therapeutics?
- What is Nektar Therapeutics annual gross profit year-on-year change?
- What is Nektar Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly gross profit year-on-year change?
- What is Nektar Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Nektar Therapeutics?
- What is Nektar Therapeutics TTM gross profit year-on-year change?
What is Nektar Therapeutics annual gross profit?
The current annual gross profit of NKTR is $56.35 M
What is the all time high annual gross profit for Nektar Therapeutics?
Nektar Therapeutics all-time high annual gross profit is $1.17 B
What is Nektar Therapeutics annual gross profit year-on-year change?
Over the past year, NKTR annual gross profit has changed by -$14.07 M (-19.97%)
What is Nektar Therapeutics quarterly gross profit?
The current quarterly gross profit of NKTR is $19.69 M
What is the all time high quarterly gross profit for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly gross profit is $1.08 B
What is Nektar Therapeutics quarterly gross profit year-on-year change?
Over the past year, NKTR quarterly gross profit has changed by +$7.98 M (+68.10%)
What is Nektar Therapeutics TTM gross profit?
The current TTM gross profit of NKTR is $63.15 M
What is the all time high TTM gross profit for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM gross profit is $1.35 B
What is Nektar Therapeutics TTM gross profit year-on-year change?
Over the past year, NKTR TTM gross profit has changed by +$7.60 M (+13.69%)